Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Men have more severe COVID-19 outcomes than women.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Microneedles offer a promising, painless way to treat skin diseases but need improvements for better use.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Understanding how melanocyte stem cells work could lead to new treatments for hair graying and skin pigmentation disorders.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Minoxidil use during pregnancy may cause fetal harm.

The ITGB6 gene is important for tissue repair and hair growth, and mutations can lead to enamel defects and other health issues.

Microneedling is a safe and effective way to improve various skin conditions with minimal side effects.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.